99 related articles for article (PubMed ID: 10368978)
1. A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays.
Brockman AH; Orlando R; Tarleton RL
Rapid Commun Mass Spectrom; 1999; 13(11):1024-30. PubMed ID: 10368978
[TBL] [Abstract][Full Text] [Related]
2. Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry.
Woods AS; Huang AY; Cotter RJ; Pasternack GR; Pardoll DM; Jaffee EM
Anal Biochem; 1995 Mar; 226(1):15-25. PubMed ID: 7785766
[TBL] [Abstract][Full Text] [Related]
3. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
4. Characterization of major histocompatibility complex-associated peptides from a small volume of whole blood.
Hopkins LM; Schall M; Leykam JF; Gerlach JA
Anal Biochem; 2004 May; 328(2):155-61. PubMed ID: 15113691
[TBL] [Abstract][Full Text] [Related]
5. The use of mass spectrometry to identify antigens from proteasome processing.
Burlet-Schiltz O; Claverol S; Gairin JE; Monsarrat B
Methods Enzymol; 2005; 405():264-300. PubMed ID: 16413318
[TBL] [Abstract][Full Text] [Related]
6. Multiple class I motifs revealed by sequencing naturally processed peptides eluted from rat T cell MHC molecules.
Burrows GG; Ariail K; Celnik B; Gambee JE; Offner H; Vandenbark AA
J Neurosci Res; 1997 Jul; 49(1):107-16. PubMed ID: 9211995
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
Antwi K; Hanavan PD; Myers CE; Ruiz YW; Thompson EJ; Lake DF
Mol Immunol; 2009 Sep; 46(15):2931-7. PubMed ID: 19615748
[TBL] [Abstract][Full Text] [Related]
8. Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
Torabi-Pour N; Nouri AM; Perrett D; Oliver RT
Biomed Chromatogr; 2001 Feb; 15(1):18-24. PubMed ID: 11180296
[TBL] [Abstract][Full Text] [Related]
9. Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.
Millo E; Pietra G; Armirotti A; Vacca P; Mingari MC; Moretta L; Damonte G
J Immunol Methods; 2007 Apr; 322(1-2):128-36. PubMed ID: 17331531
[TBL] [Abstract][Full Text] [Related]
10. Chicken major histocompatibility complex class II molecules of the B haplotype present self and foreign peptides.
Cumberbatch JA; Brewer D; Vidavsky I; Sharif S
Anim Genet; 2006 Aug; 37(4):393-6. PubMed ID: 16879355
[TBL] [Abstract][Full Text] [Related]
11. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
12. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
[TBL] [Abstract][Full Text] [Related]
13. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.
Hammer GE; Gonzalez F; Champsaur M; Cado D; Shastri N
Nat Immunol; 2006 Jan; 7(1):103-12. PubMed ID: 16299505
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive mass spectrometric analysis of the 20S proteasome complex.
Huang L; Burlingame AL
Methods Enzymol; 2005; 405():187-236. PubMed ID: 16413316
[TBL] [Abstract][Full Text] [Related]
15. Enhanced sensitivity for sequence determination of major histocompatibility complex class I peptides by membrane preconcentration-capillary electrophoresis-microspray-tandem mass spectrometry.
Naylor S; Ji Q; Johnson KL; Tomlinson AJ; Kieper WC; Jameson SC
Electrophoresis; 1998 Sep; 19(12):2207-12. PubMed ID: 9761205
[TBL] [Abstract][Full Text] [Related]
16. A new strategy for tumor antigen discovery based on in vitro priming of naive T cells with dendritic cells.
Kao H; Amoscato AA; Ciborowski P; Finn OJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):773s-780s. PubMed ID: 11300472
[TBL] [Abstract][Full Text] [Related]
17. MHC class I antigen presentation--recently trimmed and well presented.
Flutter B; Gao B
Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
Röhn TA; Reitz A; Paschen A; Nguyen XD; Schadendorf D; Vogt AB; Kropshofer H
Cancer Res; 2005 Nov; 65(21):10068-78. PubMed ID: 16267033
[TBL] [Abstract][Full Text] [Related]
19. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
20. Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.
Johnstone C; Del Val M
Traffic; 2007 Nov; 8(11):1486-94. PubMed ID: 17822406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
